MSA at NIH’s Countermeasures Against Chemical Threats (CounterACT) Symposium

June 14, 2017 

During the week beginning Sunday 6/11/17 Michael Mesa , President of Mesa Science Associates , will represent the company at the 11th Annual NIH CounterAct Research Symposium. This year’s event will be held in Boston Mass.  and will be hosted by Brigham and Women’s Hospital and The Harvard Medical School Center for CounterAct Excellence. For the 6th year Mr. Mesa will join clients and colleagues from around the world for this important medical/pharmaceutical  conference. This years’ event includes a special treat which is  a dinner at John F. Kennedy Presidential Library and Museum.

MSA News

Dr. Kenneth Dretchen PhD has been appointed as a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Discovery Research Award Committee.

May 22, 2020 This committee review grant applications for Pre-doctoral, Post-doctoral and Research Starter Grants dealing with innovative approaches that…

Read More

Mesa Science Associates and Bryn Pharma Publish Second Pre-Clinical Study of a New Approach to Treating Anaphylaxis

The second in a series of three studies measured the pharmacokinetic and heart rate effects of intranasal epinephrine in dogs….

Read More

Mesa Science Associates and Bryn Pharma Publish Pre-Clinical Study of a New Approach to Treating Anaphylaxis

April 13, 2020 Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the first of three…

Read More